Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-24

FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Original Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a generic buprenorphine and naloxone sublingual film (Original Application) for the treatment of opioid dependence, with Alvogen Inc. as the manufa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine and naloxone sublingual film (Buprenorphine and naloxone)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM (BUPRENORPHINE AND NALOXONE)